CA AB 1027
in committeeCannabis: testing: quality assurance.
California · 2025-2026 Regular Session · lower
Quick answers
Did CA AB 1027 pass?
Not yet. CA AB 1027 is in committee as of 2025-08-29 and has not come to a final vote. Latest recorded action (2025-08-29): In committee: Held under submission.
What is CA AB 1027 about?
(1) Existing law, the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , an initiative measure, authorizes a person who obtains a state license under AUMA and any applicable local ordinances to engage in commercial adult-use cannabis activity pursuant to that license, if conducted as prescribed. Existing law, the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) , among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities, and requires the Department of Cannabis Control to administer its provisions. Existing law prohibits cannabis or cannabis products from being sold by a licensee unless specified quality assurance standards and testing standards are met. Existing law requires representative samples of the cannabis or cannabis products in their final form to be tested by a licensed testing laboratory, and requires the department to develop criteria to determine which batches are tested. Existing law authorizes the testing laboratory to retest a sample if the testing laboratory notifies the department, in writing, that the test was compromised due to equipment malfunction, staff error, or another circumstance authorized by the department, and the department authorizes the retest of that sample. Existing law requires the testing laboratory to issue a certificate of analysis that the cannabis batch has passed the testing requirements, and authorizes the testing laboratory to amend the certificate of analysis to correct minor errors, as specified. This bill would specify that all cannabis or cannabis products are subject to test or retest, and would revise the retest requirements to instead authorize a testing laboratory to retest a sample of cannabis or cannabis products if either the testing laboratory notifies the department, in writing, that the test was compromised due to equipment malfunction, staff error, or other circumstances allowed by regulation, if the department requires the retest, or if the department authorizes the request. This bill would require the licensee to allow the department to obtain or access any cannabis or cannabis products held or offered for retail sale for the purposes of conducting off-the-shelf laboratory testing. The bill would also require a retailer and any other licensee authorized to engage in the retail sale of cannabis or cannabis products to provide the certificate of analysis associated with any cannabis or cannabis product held or offered for retail sale to a customer upon request. This bill would also require a testing laboratory to be subject to performance testing, as specified, to ensure consistency of results across laboratories. (2) Existing law, upon the issuance of a certificate of analysis by the testing laboratory, requires a distributor to conduct a quality assurance review before distribution of cannabis or cannabis products to ensure the labeling and packaging conform to the requirements of MAUCRSA. Existing law also requires a quality assurance compliance monitor, who is an employee or contractor of the department, to conduct random quality assurance reviews at a distributor's licensed premises before distribution to ensure the labeling and packaging of the cannabis and cannabis products conform to the requirements of MAUCRSA. This bill would repeal the requirement that a quality assurance compliance monitor conduct random quality assurance reviews, and instead would require the department to conduct those reviews. The bill would expand those reviews to include a microbusiness or retailer's licensed premises, and would require the department to additionally ensure the testing of the cannabis and cannabis products conform to the requirements of MAUCRSA. (3) Existing law authorizes a testing laboratory to receive and test samples of cannabis or cannabis products from state or local law enforcement, or a prosecuting or regulatory agency, as specified, and provides that the testing of that cannabis is not commercial cannabis activity for purposes of MAUCRSA and is not arranged or overseen by the department. This bill would require a licensed testing laboratory to comply with the department's request to evaluate the laboratory's testing practice. (4) Existing law, if the department finds or has probable cause to believe that cannabis or a cannabis product is adulterated or misbranded, or sold in violation of MAUCRSA, requires the department to affix a tag or other appropriate marking to the cannabis or cannabis product, and to give notice that the cannabis or cannabis product is in violation of MAUCRSA and has been embargoed. Existing law makes it unlawful to remove, sell, or dispose of embargoed cannabis or an embargoed cannabis product without written permission of the department or a court, and subjects each violation to a fine. This bill would remove the requirement that the department affix a tag or other appropriate marking to the cannabis or cannabis product, and instead would require the notice to reasonably identify the cannabis or cannabis product subject to the embargo. The bill would also require the licensee, within one business day of receiving a notice of the embargo, to physically separate all embargoed cannabis and cannabis products from all other inventory, as specified.
Who sponsors CA AB 1027?
Sharp-Collins is the primary sponsor of CA AB 1027, joined by 1 cosponsor.
Description
(1) Existing law, the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , an initiative measure, authorizes a person who obtains a state license under AUMA and any applicable local ordinances to engage in commercial adult-use cannabis activity pursuant to that license, if conducted as prescribed. Existing law, the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) , among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities, and requires the Department of Cannabis Control to administer its provisions. Existing law prohibits cannabis or cannabis products from being sold by a licensee unless specified quality assurance standards and testing standards are met. Existing law requires representative samples of the cannabis or cannabis products in their final form to be tested by a licensed testing laboratory, and requires the department to develop criteria to determine which batches are tested. Existing law authorizes the testing laboratory to retest a sample if the testing laboratory notifies the department, in writing, that the test was compromised due to equipment malfunction, staff error, or another circumstance authorized by the department, and the department authorizes the retest of that sample. Existing law requires the testing laboratory to issue a certificate of analysis that the cannabis batch has passed the testing requirements, and authorizes the testing laboratory to amend the certificate of analysis to correct minor errors, as specified. This bill would specify that all cannabis or cannabis products are subject to test or retest, and would revise the retest requirements to instead authorize a testing laboratory to retest a sample of cannabis or cannabis products if either the testing laboratory notifies the department, in writing, that the test was compromised due to equipment malfunction, staff error, or other circumstances allowed by regulation, if the department requires the retest, or if the department authorizes the request. This bill would require the licensee to allow the department to obtain or access any cannabis or cannabis products held or offered for retail sale for the purposes of conducting off-the-shelf laboratory testing. The bill would also require a retailer and any other licensee authorized to engage in the retail sale of cannabis or cannabis products to provide the certificate of analysis associated with any cannabis or cannabis product held or offered for retail sale to a customer upon request. This bill would also require a testing laboratory to be subject to performance testing, as specified, to ensure consistency of results across laboratories. (2) Existing law, upon the issuance of a certificate of analysis by the testing laboratory, requires a distributor to conduct a quality assurance review before distribution of cannabis or cannabis products to ensure the labeling and packaging conform to the requirements of MAUCRSA. Existing law also requires a quality assurance compliance monitor, who is an employee or contractor of the department, to conduct random quality assurance reviews at a distributor's licensed premises before distribution to ensure the labeling and packaging of the cannabis and cannabis products conform to the requirements of MAUCRSA. This bill would repeal the requirement that a quality assurance compliance monitor conduct random quality assurance reviews, and instead would require the department to conduct those reviews. The bill would expand those reviews to include a microbusiness or retailer's licensed premises, and would require the department to additionally ensure the testing of the cannabis and cannabis products conform to the requirements of MAUCRSA. (3) Existing law authorizes a testing laboratory to receive and test samples of cannabis or cannabis products from state or local law enforcement, or a prosecuting or regulatory agency, as specified, and provides that the testing of that cannabis is not commercial cannabis activity for purposes of MAUCRSA and is not arranged or overseen by the department. This bill would require a licensed testing laboratory to comply with the department's request to evaluate the laboratory's testing practice. (4) Existing law, if the department finds or has probable cause to believe that cannabis or a cannabis product is adulterated or misbranded, or sold in violation of MAUCRSA, requires the department to affix a tag or other appropriate marking to the cannabis or cannabis product, and to give notice that the cannabis or cannabis product is in violation of MAUCRSA and has been embargoed. Existing law makes it unlawful to remove, sell, or dispose of embargoed cannabis or an embargoed cannabis product without written permission of the department or a court, and subjects each violation to a fine. This bill would remove the requirement that the department affix a tag or other appropriate marking to the cannabis or cannabis product, and instead would require the notice to reasonably identify the cannabis or cannabis product subject to the embargo. The bill would also require the licensee, within one business day of receiving a notice of the embargo, to physically separate all embargoed cannabis and cannabis products from all other inventory, as specified.
- Introduced
- 2025-03-28
- Latest action
- 2025-08-29 — In committee: Held under submission.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Sharp-Collinsauthor
- Hadwickcoauthor
Committees
Not provided by source.
Action timeline
2025-02-20
Read first time. To print.
reading-1
2025-02-21
From printer. May be heard in committee March 23.
2025-03-28
From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.
amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2025-03-28
Referred to Com. on B. & P.
referral-committee
2025-04-01
Re-referred to Com. on B. & P.
referral-committee
2025-04-29
Coauthors revised.
2025-04-29
From committee: Do pass and re-refer to Com. on APPR. (Ayes 17. Noes 0.) (April 29). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2025-05-14
In committee: Set, first hearing. Referred to APPR. suspense file.
referral-committee
2025-05-23
From committee: Do pass. (Ayes 14. Noes 0.) (May 23).
committee-passage,committee-passage-favorable
2025-05-27
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2025-06-02
Read third time. Passed. Ordered to the Senate. (Ayes 79. Noes 0. Page 1871.)
passage,reading-1,reading-3
2025-06-03
In Senate. Read first time. To Com. on RLS. for assignment.
reading-1,referral-committee
2025-06-11
Referred to Com. on B. P. & E.D.
referral-committee
2025-06-18
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2025-07-14
From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (July 14). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2025-08-18
In committee: Referred to suspense file.
referral-committee
2025-08-29
In committee: Held under submission.
Versions
Documents
- application/pdf
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
Do pass and be re-referred to the Committee on [Appropriations]
2025-04-29 · pass · 17-0
Member-level votes (18)
- Caloza: yes
- Bains: yes
- Elhawary: yes
- Jackson: yes
- Krell: yes
- Ahrens: yes
- Macedo: yes
- Nguyen: yes
- Flora: yes
- Bauer-Kahan: yes
- Wilson: yes
- Chen: yes
- Lowenthal: yes
- Pellerin: yes
- Berman: yes
- Irwin: yes
- Alanis: yes
- Hadwick: other
Do pass.
2025-05-23 · pass · 14-0
Member-level votes (15)
- Calderon: yes
- Elhawary: yes
- Dixon: yes
- Hart: yes
- Mark González: yes
- Arambula: yes
- Pacheco: yes
- Solache: yes
- Ta: yes
- Caloza: yes
- Wicks: yes
- Pellerin: yes
- Fong: yes
- Tangipa: yes
- Sanchez: other
AB 1027 Sharp-Collins Assembly Third Reading
2025-06-02 · pass · 79-0
Member-level votes (79)
- Rivas: yes
- Rogers: yes
- Wicks: yes
- Irwin: yes
- Arambula: yes
- Caloza: yes
- Ward: yes
- Nguyen: yes
- Patel: yes
- Solache: yes
- Chen: yes
- Bonta: yes
- McKinnor: yes
- Pacheco: yes
- DeMaio: yes
- Celeste Rodriguez: yes
- Castillo: yes
- Sanchez: yes
- Schultz: yes
- Hadwick: yes
- Lee: yes
- Bryan: yes
- Michelle Rodriguez: yes
- Mark González: yes
- Patterson: yes
- Carrillo: yes
- Muratsuchi: yes
- Papan: yes
- Jeff Gonzalez: yes
- Ransom: yes
- Wallis: yes
- Elhawary: yes
- Davies: yes
- Macedo: yes
- Sharp-Collins: yes
- Berman: yes
- Jackson: yes
- Wilson: yes
- Lackey: yes
- Bennett: yes
- Petrie-Norris: yes
- Harabedian: yes
- Ellis: yes
- Aguiar-Curry: yes
- Connolly: yes
- Quirk-Silva: yes
- Soria: yes
- Tangipa: yes
- Gipson: yes
- Alvarez: yes
- Hoover: yes
- Ta: yes
- Zbur: yes
- Flora: yes
- Valencia: yes
- Addis: yes
- Garcia: yes
- Gallagher: yes
- Krell: yes
- Ahrens: yes
- Stefani: yes
- Calderon: yes
- Blanca Rubio: yes
- Lowenthal: yes
- Schiavo: yes
- Gabriel: yes
- Dixon: yes
- Ávila Farías: yes
- Fong: yes
- Ramos: yes
- Pellerin: yes
- Kalra: yes
- Alanis: yes
- Haney: yes
- Hart: yes
- Boerner: yes
- Bauer-Kahan: yes
- Ortega: yes
- Bains: yes
Do pass, but first be re-referred to the Committee on [Appropriations]
2025-07-14 · pass · 11-0
Member-level votes (11)
- Weber Pierson: yes
- Ashby: yes
- Archuleta: yes
- Arreguín: yes
- Smallwood-Cuevas: yes
- Niello: yes
- Menjivar: yes
- Grayson: yes
- Umberg: yes
- Choi: yes
- Strickland: yes
Placed on suspense file
2025-08-18 · pass · 7-0
Member-level votes (7)
- Richardson: yes
- Seyarto: yes
- Caballero: yes
- Cabaldon: yes
- Dahle: yes
- Wahab: yes
- Grayson: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 1027. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.